BW

EdiGene Announces Completion of Last Patient Dosing in Phase I Clinical Trial of ET-01, its Investigational Gene-editing Hematopoietic Stem Cell Therapy for Transfusion Dependent β-thalassemia

BEIJING & WALTHAM, Mass.--(BUSINESS WIRE)--EdiGene, Inc., a global, clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs, announced it had completed the last patient dosing in Phase I clinical trial of ET-01, its investigational gene-editing hematopoietic stem cell therapy for transfusion…
Leer más...

Lysogene to Provide Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study and Host Webcast on Wednesday, November 23, 2022

Live webcast to be hosted on Wednesday, November 23, 2022 at 1:30 pm CET PARIS--(BUSINESS WIRE)--Regulatory News: Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today announced that it will host a live webcast on Wednesday, November 23, 2022 at 1:30…
Leer más...

ELEVATE CREDIT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevate Credit, Inc. – ELVT

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Elevate Credit, Inc. (NYSE: ELVT) to an affiliate of Park Cities Asset Management LLC. Under the terms of the proposed transaction,…
Leer más...

Project Venkman Selects Hypermint by Moonpay for Its NFT Minting

The ‘Bill Murray 1000’ is now powered by Moonpay’s Hypermint! AUSTIN, Texas--(BUSINESS WIRE)--Project Venkman, a web3 membership platform, announced a collaboration with Moonpay to build out its debut membership NFT collection, the Bill Murray 1000. The collection has earned industry accolades as being the "blueprint" for celebrity memberships, according to…
Leer más...

Cathay General Bancorp Declares $0.34 Per Share Dividend

LOS ANGELES--(BUSINESS WIRE)--Cathay General Bancorp (Nasdaq: CATY) announced that its Board of Directors declared a cash dividend of thirty-four cents per common share, payable on December 9, 2022, to stockholders of record at the close of business on November 29, 2022. ABOUT CATHAY GENERAL BANCORP Cathay General Bancorp is the…
Leer más...

BIRD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Bird Global, Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Bird Global, Inc. (“Bird” or the “Company”) (NYSE: BRDS) in the United States District Court of Central California on behalf of all persons and entities who…
Leer más...

RITE AID ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Rite Aid Corporation and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD) in the United States District Court of Eastern Pennsylvania on behalf of all persons and entities…
Leer más...

DLOCAL ALERT: Bragar Eagel & Squire, P.C. is Investigating DLocal Ltd on Behalf of DLocal Stockholders and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against DLocal Ltd (“DLocal” or the “Company”) (NASDAQ: DLO) on behalf of DLocal stockholders. Our investigation concerns whether DLocal has violated the federal securities laws and/or engaged in other unlawful business practices.…
Leer más...